Government signs agreement with BioNTech SE to provide up to 10,000 patients with precision cancer immunotherapies by 2030 NHS England’s new Cancer Vaccine Launch Pad aims to improve access to personalised treatments and clinical trials BioNTech SE to set up laboratories and a regional hub in England to support the development of immunotherapies

Ground-breaking

Continue reading MAJOR AGREEMENT TO DELIVER NEW CANCER VACCINE TRIALS